Related Experiment Videos
Laparoscopic evaluation in pancreatic cancer
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Seminars in Surgical Oncology
|October 21, 1998
Summary
Pancreatic cancer staging using laparoscopy with ultrasound is more accurate than CT scans for detecting small metastases. This approach improves surgical decisions and allows for minimally invasive palliative procedures.
Area of Science:
- Oncology
- Surgical Oncology
- Diagnostic Imaging
Background:
- Pancreatic cancer has a poor prognosis, with most patients presenting with advanced disease.
- Dynamic contrast-enhanced computed tomography (CT) is standard for pre-operative staging but has limitations in predicting resectability.
- CT is sensitive for unresectability but less accurate for determining safe tumor resection.
Purpose of the Study:
- To evaluate the efficacy of laparoscopic staging compared to dynamic CT in peri-ampullary tumors.
- To assess the added benefit of laparoscopic ultrasound in determining tumor resectability.
- To compare the accuracy and morbidity of laparoscopic staging versus open exploration.
Main Methods:
- Laparoscopic staging of peri-ampullary tumors.
- Addition of laparoscopic ultrasound during staging.
- Comparison with dynamic contrast-enhanced CT findings.
- Evaluation of morbidity and mortality rates.
Main Results:
- Laparoscopy is superior to dynamic CT in visualizing small liver and peritoneal metastases.
- Laparoscopic ultrasound enhances the assessment of tumor resectability.
- Laparoscopic staging approaches the accuracy of open exploration with lower morbidity.
- Laparoscopic palliative bypass procedures can be performed for unresectable cases.
Conclusions:
- Laparoscopic staging, particularly with ultrasound, offers improved accuracy for peri-ampullary tumors over CT.
- This minimally invasive approach aids in surgical decision-making and can reduce the need for laparotomy.
- Laparoscopic procedures can be safely performed for palliative care in unresectable pancreatic cancer.